Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vita Coco Company (COCO) Shares Outstanding (Weighted Average) (2020 - 2025)

Vita Coco Company (COCO) has disclosed Shares Outstanding (Weighted Average) for 6 consecutive years, with $56.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) changed 0.33% to $56.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $56.9 million, a 0.33% change, with the full-year FY2025 number at $56.9 million, changed 0.33% from a year prior.
  • Shares Outstanding (Weighted Average) was $56.9 million for Q4 2025 at Vita Coco Company, roughly flat from $56.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $57.0 million in Q1 2025 to a low of $53.0 million in Q2 2021.
  • A 5-year average of $55.8 million and a median of $56.3 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): fell 9.38% in 2021, then increased 5.0% in 2022.
  • Vita Coco Company's Shares Outstanding (Weighted Average) stood at $53.7 million in 2021, then grew by 3.8% to $55.7 million in 2022, then grew by 1.25% to $56.4 million in 2023, then increased by 0.53% to $56.7 million in 2024, then grew by 0.33% to $56.9 million in 2025.
  • Per Business Quant, the three most recent readings for COCO's Shares Outstanding (Weighted Average) are $56.9 million (Q4 2025), $56.9 million (Q3 2025), and $56.9 million (Q2 2025).